ENTITY
Eris Lifesciences

Eris Lifesciences (ERIS IN)

79
Analysis
Health Care • India
Eris Lifesciences is an Indian pharmaceutical company that develops, manufactures, and markets branded formulations. The company focuses on chronic and sub-chronic therapies, including products for cardiovascular disorders, diabetes, pain management, gastroenterology, and dermatology. Eris Lifesciences was founded in 2007 and is headquartered in Ahmedabad, Gujarat, India.
more
bullish•Mankind Pharma
•19 Apr 2023 12:18

Mankind Pharma IPO - Quality Name but Might Not Have a Whole Lot of Upside

Mankind Pharma (MP) is looking to raise up to US$527m in its upcoming India IPO. In this note, we talk about the implied valuations.

Logo
674 Views
Share
bullish•Indegene
•19 Apr 2023 10:51

Indegene Pre-IPO - Growing Client Base and Cross/Up-Selling Led to Growth

Indegene Limited (1864095D IN) is looking to raise about US$400m in its upcoming India IPO. Indegene is a “digital-first” commercialisation firm...

Logo
702 Views
Share
bullish•Mankind Pharma
•18 Apr 2023 17:04

Mankind Pharma Pre-IPO - RHP Updates - A Mixed Bag

Mankind Pharma  (MP) is now looking to raise around US$500m in its upcoming India IPO. In this note we talk about the updates from its recently...

Logo
477 Views
Share
bullish•Blue Jet Healthcare
•16 Mar 2023 10:50

Blue Jet Healthcare Pre-IPO - Marquee Clients but Inconsistent Growth and Margins

Blue Jet Healthcare Ltd (BJHC IN)  is looking to raise about US$300m in its upcoming India IPO. In this note, we talk about the past performance.

Logo
696 Views
Share
bullish•Mankind Pharma
•09 Feb 2023 10:55

Mankind Pharma Pre-IPO - Thoughts on Valuations

Mankind Pharma  is looking to raise about US$1bn in its upcoming India IPO. In this note, we will talk about valuations.

Logo
654 Views
Share
x